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Background: Over-proportionally high energy requirements in some patients with
anorexia nervosa (AN) have been reported, but their exact origin remains unclear.
Objective: To objectively measure metabolic alterations in an AN patient with high
energy requirements as judged by clinical observation.
Materials and Methods: We present the case of a young woman with AN (index
patient, IP; 19 years, admission BMI 13.9 kg/m2). After 3 months of treatment at BMI 17.4
kg/m2, we assessed her resting energy expenditure (REE), respiratory exchange ratio
(RER), diet-induced thermogenesis (DIT), seated non-exercise physical activity (NEPA
in Volt by infrared sensors), and exercise activity thermogenesis (EAT) in a metabolic
chamber; body composition (bioimpedance analysis), energy intake (15d-food protocol),
physical activity (accelerometry) and endocrine parameters. The IP was compared for
REE, RER, DIT and seated NEPA to six AN patients (AN-C) and four healthy women
(HC-1), and for EAT to another six healthy women (HC-2).
Results: Our IP showed high REE (110% of predicted REE according to Harris &
Benedict) and high seated NEPA (47% increase over AN-C, 40% over HC-1), whereas
DIT (IP: 78 vs. HC-1: 145 ± 51 kJ/180min) and EAT (IP: 157 vs. HC-2: 235 ± 30
kJ/30min) were low, when compared with HC. The other AN patients showed a lower
REE (AN: 87 ± 2% vs. HC: 97 ± 2% predicted) at increased DIT (AN: 187 ± 91 vs. HC:
145 ± 51 kJ/180min) when compared with HC. RER of the IP was low (IP: 0.72 vs. 0.77
in AN-C; 0.77 in HC-1 and 0.80 in HC-2).
Conclusions: Complex and variable disturbances of energy metabolism might exist in
a subgroup of patients with AN during refeeding, which could lead to unexpectedly high
energy requirements. Future studies need to confirm the existence, and investigate the
characteristics and prevalence of this subgroup.
Clinical trial Registry number: NCT02087280, https://www.clinicaltrials.gov/
Keywords: anorexia nervosa, energy requirements, energy metabolism, metabolic chamber, seated non-exercise
physical activity
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INTRODUCTION
Anorexia nervosa (AN) is a severe psychiatric illness, with some
patients requiring intensive and repeated inpatient care. The
main aim of treatment for patients with AN is to normalize body
weight. Recommendations about caloric intakes to gain weight
for these patients vary from 30 to 100 kcal/kg/d (1), depending on
individual nutritional characteristics, physical activity level and
treatment phase.
High caloric requirements for weight gain have been reported
in some individuals with AN, i.e., occurring at week 6 of
treatment, of >95 kcal/kg/d, which would result in 4,750 kcal
for a patient weighing 50 kg (1). However so far, most studies
on energy requirements in AN patients rely on the observation
of food intake and/or the prediction equations from healthy
persons—both of thesemethods have limited accuracy in patients
with AN. Resting energy expenditure (REE) is usually decreased
at the start of treatment and increases with weight regain (2). In
one individual with AN, REE at the completion of refeeding was
reported to be 19% higher than expected for height and weight
(3). The exact origin of these high requirements in some AN
patients remain unclear.
We hypothesized that in some AN patients, high energy
requirements represent a metabolic barrier to weight gain and
maintenance. Therefore, we intended to subject an AN patient
with high caloric requirements for weight gain, as judged
by clinical observation, to extensive and objective metabolic
evaluations in order to gain a better understanding of her
metabolic status.
MATERIALS AND METHODS
Body Composition Analysis and Food
Intake
Body composition analysis of the index patient was carried
out with bioelectrical impedance analysis (BIA-Corpus, Medical
Health Care, Karlsruhe, Germany) in combination with the
manufacturer electrodes and software (BodyComp V9, scientific-
pro). Energy and macronutrient intake of the index patient were
assessed over 15 days using food protocols (optidiet, GOE mbH,
Linden, Germany).
Energy and Substrate Metabolism
We assessed three major components of energy expenditure (EE)
in a metabolic respiratory chamber as described previously (4),
i.e., resting energy expenditure (REE) after an overnight 12-h fast,
Respiratory Exchange Ratio (RER, ratio between carbon dioxide
produced and oxygen consumed (VCO2/VO2), diet-induced
thermogenesis (DIT) after a test meal, and exercise activity-
induced thermogenesis (EAT). EAT during 30min of moderate
bicycle exercise is expressed as energy efficiency (workload/EE
during exercise) to account for different workloads of the IP and
healthy controls. During the entire test protocol, physical activity
was recorded by three passive infrared sensors (PIRS) in the
chamber. For the detailed test protocol, see Figure 1. Test results
of the IP were compared to data from respective control patients
from our institutional database: for REE, DIT, RER and seated
non-exercise physical activity (NEPA) from six anorexic female
patients (AN-C) and four healthy, age-matched women (healthy
controls, HC-1); for EAT from another six healthy women (HC-
2; Table 1, Figure 2). The AN-C patients had been admitted to
inpatient treatment for amean of 3.7 (range: 2.1–5.4) months and
had gained 4.6 (range: 3.2–5.6) kg between admission and the test
day (BMI increase from 15.0 to 16.3 kg/m2).
Physical Activity (PA)
PA was assessed by accelerometry using a SenseWearTM armband
and software, Version 8.0 (both BodyMedia, Inc., Pittsburgh, PA,
USA). PA of the index patient was continuously measured for 5
days in the week after metabolic evaluation.
Endocrine Parameters
We assessed the following hormones of the index patient with a
possible modulating effect of PA in AN: cortisol and leptin by the
routine laboratory of Charité-Universitätsmedizin Berlin, as well
as nucleobindin2 (NUCB2)/nesfatin-1 (# EK-003-26, Phoenix
Pharmaceuticals, Inc., Burlingame, CA, USA) and phoenixin
(EK-079-01, Phoenix Pharmaceuticals, Inc.) by using ELISA.
Statistical Analysis
To compare metabolic test results of AN-C and HC, the Saphiro-
Wilk test was used to test for normal distribution. If data were
distributed normally, an independent samples t-test was applied,
and for non-normally distribute data, the Wilcoxon test.
Ethics
This study was carried out in accordance with the
recommendations of good scientific practice guidelines
and approved by the ethical committee of the Charité-
Universitätsmedizin Berlin. All subjects gave written informed
consent in accordance with the Declaration of Helsinki. In
addition, the patient providing the case for the present report




A 19-year old woman diagnosed with anorexia nervosa,
restrictive subtype (AN; subsequently referred to as index patient,
IP) was admitted to the inpatient psychosomatic clinic at the
University Hospital Bochum, Germany in April 2015. At that
time, her body weight was 44.5 kg (97.9 lbs) corresponding
to a body mass index (BMI) of 13.9 kg/m2. Amenorrhea was
present, a body image disorder was only slightly pronounced. Her
estimated premorbid BMI assessed by a patient interview was
23 kg/m2 at the age of 15. A previous attempt in a community
hospital in order to restore weight had been unsuccessful.
The IP showed oriented awareness, was clear to all
dimensions, and appeared in slightly reduced force. Apart
from specific eating disorder thoughts revolving around food
and weight, formal or substantive thought disorders could be
excluded. Alcohol and any drug abuse were denied. At admission,
she was on 15mg mirtazapine per day. Basic serum chemistry
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FIGURE 1 | Test protocol in the metabolic chamber. REE, Resting Energy Expenditure; DIT, Diet-induced thermogenesis; VO2 and VCO2, oxygen and carbon dioxide
volumes.
TABLE 1 | Baseline characteristics and calorimetric measurements of the index patient at rest and after stimulation.
Index patient AN-control healthy-control 1 DIT Healthy-control 2 exercise
N 1 6 4 6
Age (years) 20 20 ± 8 23 ± 1 52 ± 6**
Height (m) 1.77 1.62 ± 0.05 1.71 ± 0.03* 1.70 ± 0.06*
Weight (kg) 54.4 43.0 ± 1.3 62.8 ± 5.8** 67.2 ± 3.1***
Weight (lbs) 119.7 94.6 ± 2.9 138.2 ± 12.8** 147.8 ± 6.8***
BMI (kg/mE2 ) 17.4 16.3 ± 0.3 21.4 ± 1.6* 23.3 ± 1.6**
REE (kcal/d) 1622 1161 ± 68 1492 ± 136** 1437 ± 158**
REE (% predicted) 109.6 86.9 ± 2.4 97.1 ± 1.7*** 99.8 ± 8.1**
Basal RER 0.72 0.77 ± 0.03 0.80 ± 0.05 0.75 ± 0.04
DIT (kJ/180min) 78 187 ± 91 145 ± 51 n.d.
Work load (Watt) 30 n.d. n.d. 40 ± 0
Energy efficiency (%) 34.4 n.d. n.d. 31.5 ± 4.1
Mean PIRS (Volt) 0.28 0.19 ± 0.01 0.20 ± 0.01 n.a.
Data of the index patient are compared to 6 AN patients (AN-control) and 4 controls (healthy control 1) after a test meal and to 6 controls (healthy control 2) after 75 g glucose and
during 30min bicycle exercise.
AN, anorexia nervosa; BMI, Body Mass Index. REE, resting energy expenditure; RER, respiratory exchange ratio; DIT, diet-induced thermogenesis; PIRS, passive infrared motion sensors;
EAT, Exercise activity thermogenesis; REE (% predicted according to Harris & Benedict); n.d., not determined; Data are displayed as mean ± SD; *p < 0.05, **p < 0.01; ***p < 0.001
when compared with AN-controls.
including blood sedimentation was within normal limits.
Complete blood count indicated a reduced leucocyte number
(3.7 × 103/µL). Activities of aspartate (39 U/L) and alanine
aminostransferase (29 U/L), and of gamma glutamyl transferase
(66 U/L) were within normal ranges. Creatine kinase was
elevated (320 U/L). All other laboratory parameters (electrolytes,
lipase, amylase, albumin, phosphate, direct and total bilirubin
levels, creatinine, glomerular filtration rate, urine analysis)
were within normal limits. Thyroid hormones, transglutaminase
IgA and endomysium IgA (to exclude celiac disease) were
normal. Extensive somatic diagnostics did not indicate any signs
for malignancies, gastrointestinal malabsorption, inflammatory
bowel disease and endocrine or exocrine pancreatic dysfunction.
Clinical chemistry did not show any evidence for a refeeding
syndrome at any time.
The IP reported high caloric requirements (4,000 kcal) in
order to gain weight. This statement usually raises concerns
regarding patients’ therapy adherence, because AN patients
often avoid weight gain by not eating enough, vomiting,
taking laxatives or exercising excessively. The IP denied all
counterproductive behaviors. Thus, after initial low energy
intake, her meal plan in the later refeeding phase was adjusted
to 4,000 kcal/d resulting in a steady increase in body weight
(Figure 3). Usually at this stage, our patients achieve weight
gain with considerably lower caloric intakes (around 2,500–3,000
kcal/d).
Metabolic Evaluation
In July 2015, the IP was referred to the metabolic ward at
the Charité-Universitätsmedizin Berlin in order to test for any
disturbances within the regulation of energy metabolism. Body
composition analysis indicated a fat mass of 8.6 kg (18.9 lbs,
15.8% of body weight), which is about 13% lower than in normal
weight healthy young women. Fat free mass was 45.8 kg (100.8
lbs) and hence within the low normal range. Mean energy intake
assessed over 15 days by food protocols was 3,940 kcal/d. This
was achieved by eating six meals daily, including a late evening
meal consisting mostly of sweets (i.e., 325 g of cookies and four
chocolate bars) or full fat sweetened dairy products (i.e., 500 g of
ice cream and 200 g of chocolate). Physical activity as assessed
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FIGURE 2 | Metabolic test results of the index patient (gray circles) and either 6 AN patients (filled circles) or 4 healthy controls (open circles). Resting (before test
meal) and diet-induced energy expenditure (A: absolute, B: relative change). Exercise activity thermogenesis after a 75 g glucose drink during 30min on a bicycle
ergometer at 0.5 W/kg body weight (C: absolute, D: relative change).). PIRS: passive infrared motion sensors for assessing non-exercise physical activity inside the
metabolic chamber (E: while seated; F: during exercise). Data expressed as mean ± SEM.
with accelerometry yielded an estimated 24-h EE of our IP of
2,632 kcal/d with 14.967 steps per day.
Resting Energy Expenditure (REE)
Surprisingly, REE of our IP was increased compared to both
AN-C and HC-1 (Table 1). RER values close to 0.70 indicate
almost 100% fat oxidation, a value close to 1.00 almost 100%
carbohydrate oxidation. Interestingly, with 0.72 basal RER of the
IP was low (Table 1).
Diet-Induced Thermogenesis (DIT)
The increase in EE in absolute values of the IP after the test meal
seemed comparable to HC-1, at least within the first 120min
after the meal (Figure 2, left, top). However, the relative increase
above REE indicated that there was just a 1.2-fold increase within
the first 60min after the meal followed by a decrease reaching
baseline values within the next 120min. In HC-1, EE increased
about 1.3-fold within 90min and in AN-C about 1.4-fold with
120min after the meal (Figure 2, left, middle). Therefore, DIT
was highest in AN-C and lowest in the IP.
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FIGURE 3 | Energy intake (based on information from the patients nutritional
diary) and body weight (early morning, fasted, taken weekly) during inpatient
treatment.
Seated Non-exercise Physical Activity (NEPA)
According to the PIRS data, the IP showed a much higher
seated NEPA level compared to AN-C and HC-1 (Figure 2, left,
bottom).
Exercise Activity Thermogenesis (EAT)
During low intensity bicycle exercise after a glucose load, EE
increased about 3-fold within the first 10min in HC-2 and
remained at that level until the end of testing (Figure 2, right, top
and middle). In the IP, EE also increased within the first 20min
of exercise followed by a rapid decrease within the next 10min.
PIRS signals during exercise were comparable between the IP and
HC-2 (Figure 2, right, bottom).
Endocrine Data
In the week of metabolic testing, cortisol of the IP was high
(452 nmol/l vs. reference range of 124–388 nmol/l). Phoenixin
of the IP was 0.31 ng/ml (reference range unknown), while leptin
was in the low normal range (2.2 vs. reference of 1.0–5.6 µg/l).
With 0.64 ng/ml NUCB2/nesfatin-1 was high (reference range ∼
0.2 ng/ml). In addition, thyroid hormones were assessed 2 weeks
prior to metabolic testing and yielded the following results: FT3,
2.3 pg/ml (reference of 2.0–4.4); FT4, 1.1 ng/dl (reference of
0.9–1.7); TSH 2.21 (reference of 0.27–4.20).
Further Course of Treatment
Body weight course during inpatient treatment as well as caloric
intake of the IP (data derived from her personal nutritional
diary) are shown in Figure 3. Her intake ranged between 46
and 101 kcal per kg body weight, was never below 2,500 kcal/d,
with a peak intake of 5,000 kcal/d. After the tests, the IP
was continued on a high energy meal plan and discharged in
September 2015 with a body weight of 54.7 kg (120.3 lbs, BMI
17.5 kg/m2). We recommended specific nutrition counseling
after discharge to meet increased energy requirements. A brief
email-interview with the IP was carried out 14 months after
metabolic investigations to gain her prespective on the tests
(interview is provided as appendix).
DISCUSSION
This case report indicates that there might be complex and
largely variable disturbances of energy metabolism in some
AN patients during refeeding. The index patient (IP) showed
increased resting energy expenditure (REE)b and seated non-
exercise physical activity (NEPA), whereas diet- and exercise-
induced thermogenesis were decreased. In contrast, the other
AN patients showed a decreased REE, normal seated NEPA and
increased diet-induced thermogenesis. With 2,500–5,000 kcal/d
(46–101 kcal/kg/d), the energy intake during inpatient treatment
reported by the IP was high. This high requirement for weight
gain in some individuals with AN is in accordance with earlier
studies (1, 5). The strength of our study is the direct and
objective assessment of energy metabolism explaining the high
requirements of the index patient (IP).
Hypermetabolism can be defined as an REE above 110% of
predicted values according to weight, height, age and gender
(6). In acute AN, REE is usually decreased due to metabolic
adaptation to starvation, i.e., to 70 ± 18 (50–93)% of predicted
REE and increases to 102 ± 13 (94–119)% at completion of
refeeding (3). Interestingly, despite sitting obviously relaxed in
an armchair, our IP showed high non-exercise physical activity
(NEPA) when measuring REE and DIT as indicated by the
three PIRS suggesting increased seated NEPA by almost a factor
of 1.5 compared to healthy controls and other AN patients.
A recent study using a novel shoe-based monitor to detect
“fidgeting” (seated NEPA) in AN patients also reported increased
activity values for AN patients at different stages of inpatient
treatment when compared with matched controls (7). Possibly,
in the situation of increased seated NEPA, REE might have been
overestimated in our study. While increased NEPA, induced by
walking, standing and fidgeting is commonly observed in AN
patients treated in clinical settings and could explain why some
patients are resistant to weight gain, very few studies exist that
specifically and objectively assessed and quantified this form of
PA in AN patients
DIT of our IP was substantially reduced and no more
measurable at the end of testing. In both control groups, DIT
was still active at the end of testing. In another study, DIT
was rather increased in AN patients during early refeeding (8).
Reasons for a reduced DIT in our IP (tested in the late refeeding
phase) might be impairments in nutrient digestion, resorption,
transport and storage. Possibly, a change in gut microbiota might
affect energy needs, as maintenance of gut bacterial population
requires substantial amount of energy (9). Taking into account
the increased seated NEPA, DIT might have been even lower
in the IP. Other authors hypothesized about a “metabolic waste
phenomenon” in AN, such as low efficiency of lean tissue for
energy storage (8), and a decreased hepatic glucose oxidation
capacity during weight restoration (10). With 0.72 basal RER of
the IP was low when compared to both control groups. A high
RER indicates low fat oxidation capacity and has been linked to
higher rates of weight gain in AN (10) and obese subjects (11).
We compared the physical activity of the IP with 39 adult AN
inpatients assessed in our unit before (12), showing moderate
(6331 ± 423 steps/d), high (13,743 ± 1047 steps/d), and
sometimes excessive PA (up to about 26,000 steps/d). Thus with
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14,967 steps/d, physical activity of our IP was high, but not
excessive. However, EAT of our IP during testing in ourmetabolic
chamber was lower when compared to healthy controls. Possibly,
the preceding glucose load was not sufficient for fueling EAT and
internal energy stores could not sufficiently be mobilized.
In past studies, increased PA in AN was associated with
hypercortisolemia (13), while for leptin conflicting data exist
(14, 15). In the IP, cortisol was slightly elevated and leptin in the
low normal range. Phoenixin and nesfatin-1 both are recently
discovered peptides associated with an effect on locomotor
activity in rats (16, 17). Whether these experimental findings can
be translated to humans requires further investigation. So far no
reference values exist in humans for phoenixin. NUCB2/nesfatin-
1 levels of our IP were 0.64 ng/ml, which is considerably higher
compared to previous studies (mean ± SD: 0.22 ± 0.19 ng/ml)
in AN patients (18) and may contribute to the increased energy
expenditure observed here as suggested in animals before (19).
Clinical Implications and Future Directions
Inpatient AN therapy has limitations, about 30–50% of patients
require re-admission within 12 months after discharge due
to renewed weight loss (20). Psychological variables such as
persisting body dissatisfaction, but also biological mechanisms
might contribute to the difficulties to gain and maintain weight.
Earlier studies suggested abnormally high caloric requirements in
some patients with AN (1, 21, 22). However, these studies relied
on observing food intake and predicting caloric intake—both
techniques with limited validity.
In obesity decreased REE after dieting accounts for quick
weight regain (“yoyo-effect”). Homeostatic responses to weight
perturbation encompass coordinated changes in behavior
and vegetative systems controlling EE. These responses are
coordinated in a manner to oppose weight perturbation in
either direction (23). Concomitantly, experimental overfeeding
in healthy male volunteers increased EE, using up to 70% of the
extra energy ingested. Two-thirds of the increases in total daily
EE was due to increased non-exercise activity thermogenesis
(NEAT), and changes in NEAT accounted for the 10-fold
differences in fat storage that occurred and directly predicted
resistance to fat gain with overfeeding (24). The longer an
experimental intervention of experimental overfeeding in healthy
men, the higher was the difference between expected and actual
weight gain (25). Resistance to continuous weight gain and
maintenance, particularly in the late treatment phase, would have
crucial therapeutic implications for AN patients. Over 20 years
ago, Vaisman et al. pointed out that a better understanding of
energy metabolism during refeeding AN patients is necessary
to provide a rational basis for nutritional management (26).
However, so far metabolic considerations are not incorporated
in AN therapy (1). We hope that the present study will raise
awareness within a broad forum of experts and care providers
working with AN patients, that a lack of weight gain in AN
could—at least in a subgroup of patients—be of biological
origin. Not correctly identifying or accusing these patients of
manipulation will strain their relation to the therapeutic team,
decrease therapy adherence and success and ultimately promote
relapse.
It is our intention to strengthen metabolic research in the
eating disorder field, by pointing out the following future
directions:
1 To confirm the existence of the above mentioned biological
barriers to weight gain in AN patients by investigating
larger AN populations at different and well-defined phases
of nutritional recovery, and to assess their effects on the
therapeutic outcome
2 To better characterize the biological origin of high energy
requirements in some AN patients, by identifying
a) biological phenotypes with high energy requirements
before the onset of AN or at the start of therapy
b) the effect of different components of energy expenditure
including non-exercise physical activity
c) the effect of relative “overfeeding” or “over-consumption”
of energy dense food during treatment
d) alterations in gut microbiota
3 To use objective measurement techniques to quantify EE
in AN patients rather than to rely on observations of
energy intake and to carefully select comparable patients and
treatment phases
Study Limitations
Our findings are based on a single case and need confirmation in
further studies. In addition, we were not able to provide data on
the metabolic status of the IP during weight loss or at the start of
treatment. There were two methodological limitations: first, the
control group for EAT was not age matched, which could have an
influence when comparing the results. Second, we assessed body
composition only in the IP, and high fat free mass could be at
least one reason for her high REE. However, we believe that the
movement registration by infrared sensors and the resulting high
SPA was unaffected by body composition.
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APPENDIX
Patient perspective (14 months after metabolic assessment, via
email)
Question 1: How would you evaluate your participation in the
study in retrospect?
Answer 1: I thought it was fun to be part of a research
project. Moreover, the study made it clear to me, that general
recommendations about energy needs that you can find in
the internet are not reliable. Before the study, I used these
recommendations as orientation, and first, I found it hard to
believe, thatmy energy expenditure could be somuch higher. Yet,
the study results showed just that. On one hand, the high energy
expenditure was a burden for me during my time in the clinic.
I often had to eat despite not being hungry or having appetite.
Because I consumed most calories in the evening as sweets, I
often went to bed feeling very sick, unwell and with hot flashes.
It also made it difficult for me to fulfill the treatment contract in
terms of the expected weekly weight gain. On the other hand, it
was good to know that I could and had to eat a lot to gain weight.
One part of me also enjoyed being able to eat so much.
Question 2: Where do you see room for improvement of
nutritional therapy for AN patients?
Answer 2: I think it would be important that patients with high
energy expenditure like me should be recognized earlier and
be taken more seriously by professionals. I am well aware that
many AN patients often just claim that they eat a lot and still
do not gain weight, or that this is their subjective perception.
Accordingly, these statements cause skepticism in the treating
teams. For me, it was helpful to get two special permits during
my inpatient stay: first, the expected rate of weight gain was
reduced by 200 g. Second, I was allowed to give sweets, dry
fruit and nuts into storage with the staff, which I could pick
up whenever I wanted to. For me it was not an option to
cover the extra calories by liquid meals. Actually, I like eating,
therefore I wanted to be able to gain my weight by eating
enjoyable food, that before I had not permitted myself to eat for
months.
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